InspireMD Reveals Inducement Grants in Accordance with Nasdaq Listing Rule 5635(c)(4)

Inducement Grants Announcement: InspireMD, Inc. has approved inducement grants of 122,054 shares of restricted stock to eight new non-executive employees as part of their 2024 Inducement Plan, effective November 20, 2025.

Vesting Schedule: The restricted stock will vest over three years, with one-third vesting on the first anniversary and the remainder in two equal installments on the second and third anniversaries, contingent on continued employment.

Company Overview: InspireMD focuses on developing the CGuard® Prime carotid stent system using its MicroNet™ mesh technology, aiming to set industry standards for carotid stenting and improve stroke prevention outcomes.

Forward-Looking Statements: The press release includes forward-looking statements regarding the company's future performance and risks, emphasizing uncertainties related to financial stability, regulatory approvals, and market competition.